Kaleido Biosciences
Kaleido Biosciences is a biotechnology company making discoveries in genetic and metabolic diversity of the human microbiome into treatment and therapies for a wide range of diseases.
4
Funding Rounds
$230.9m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ge****** vo* Ma****** |
|
- | linkedin twitter facebook instagram |
| No**** Af**** | - | - | linkedin twitter |
Funding
Funding series
Funding Series Analysis
The company Kaleido Biosciences has raised a total of $230.9m in funding over 4 rounds.
Key Insights:
- Kaleido Biosciences Venture round, February 4, 2021: $60.4m
- Kaleido Biosciences Series C round, June 26, 2018: $101m
- Kaleido Biosciences Series B round, September 18, 2017: $65m
- Kaleido Biosciences Series A round, August 13, 2015: $4.5m
Kaleido Biosciences Venture round, February 4, 2021
$60.4m
Kaleido Biosciences Series C round, June 26, 2018
$101m
Kaleido Biosciences Series B round, September 18, 2017
$65m
Kaleido Biosciences Series A round, August 13, 2015
$4.5m
Industries
Kaleido Biosciences is active in the following industries:
- Microbiology
- Consumer biotechnology
- Biotechnology
- Microbiome
- Biology
- Technology
- Engineering
- Biomedical engineering
- Biopharmaceutical